Key result
Glycemic control anchors multidrug T2D therapy to prevent microvascular and macrovascular complications.
Key points are not available for this paper at this time.
Type 2 diabetes is a chronic and progressive condition associated with the risk of invalidating micro- and macrovascular complications. Hyperglycemia is the hallmark of the condition and, despite much discussion, glycemic control remains a main goal of treatment in the attempt to prevent chronic complications.
No takes yet. Share an insight, caveat, or question.
Miccoli et al. (2011) studied this question. Glycemic control remains the primary goal of multidrug treatment in type 2 diabetes to prevent chronic microvascular and macrovascular complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: